Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year
Jenneke Leentjens, Thijs F. van Haaps, Pieter Wessels, et al.
The Lancet Haematology (2021) Vol. 8, Iss. 7, pp. e524-e533
Open Access | Times Cited: 219

Showing 1-25 of 219 citing articles:

Pathological sequelae of long-haul COVID
Saurabh Mehandru, Miriam Mérad
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 194-202
Open Access | Times Cited: 583
Innate immunity: the first line of defense against SARS-CoV-2
Michael Diamond, Thirumala‐Devi Kanneganti
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 165-176
Open Access | Times Cited: 494
Long-term complications of COVID-19
Amar D. Desai, Michael P. Lavelle, Brian C. Boursiquot, et al.
AJP Cell Physiology (2021) Vol. 322, Iss. 1, pp. C1-C11
Open Access | Times Cited: 350
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium
Diana A. Gorog, Robert F. Storey, Paul A. Gurbel, et al.
Nature Reviews Cardiology (2022) Vol. 19, Iss. 7, pp. 475-495
Open Access | Times Cited: 251
A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
Douglas B. Kell, Gert Jacobus Laubscher, Etheresia Pretorius
Biochemical Journal (2022) Vol. 479, Iss. 4, pp. 537-559
Open Access | Times Cited: 209
CT of Post-Acute Lung Complications of COVID-19
Joshua J. Solomon, B. Heyman, Jane P. Ko, et al.
Radiology (2021) Vol. 301, Iss. 2, pp. E383-E395
Open Access | Times Cited: 175
Long-Term Effects of COVID-19
Shreeya Joshee, Nikhil Vatti, Christopher Chang
Mayo Clinic Proceedings (2022) Vol. 97, Iss. 3, pp. 579-599
Open Access | Times Cited: 91
Hypercoagulability, endotheliopathy, and inflammation approximating 1 year after recovery: Assessing the long‐term outcomes in COVID‐19 patients
Bingwen Eugene Fan, Shiun Woei Wong, Christina Lai Lin Sum, et al.
American Journal of Hematology (2022) Vol. 97, Iss. 7, pp. 915-923
Open Access | Times Cited: 67
Anti-Xa activity below range is related to thrombosis in patients with severe COVID-19
Pilar Marcos-Neira, Cristian Morales‐Indiano, Mariana Fernández‐Caballero, et al.
Medicina Intensiva (2025) Vol. 49, Iss. 2, pp. 78-87
Closed Access | Times Cited: 1
SARS‐CoV‐2 infection and venous thromboembolism after surgery: an international prospective cohort study
Zineb Cherkaoui, Antonio D'Urso, Emanuele Felli, et al.
Anaesthesia (2021) Vol. 77, Iss. 1, pp. 28-39
Open Access | Times Cited: 100
Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19
Loes H. Willems, Magdolna Nagy, Hugo Ten Cate, et al.
Thrombosis Research (2021) Vol. 209, pp. 106-114
Open Access | Times Cited: 71
Editor's Choice – Update of the European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia in Light of the COVID-19 Pandemic, Based on a Scoping Review of the Literature
Vincent Jongkind, J J Earnshaw, Frederico Bastos Gonçalves, et al.
European Journal of Vascular and Endovascular Surgery (2021) Vol. 63, Iss. 1, pp. 80-89
Open Access | Times Cited: 65
Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial
Parham Sadeghipour, Behnood Bikdeli, Azita H. Talasaz, et al.
BMJ (2022), pp. e068407-e068407
Open Access | Times Cited: 65
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients
Adam Cuker, Eric Tseng, Robby Nieuwlaat, et al.
Blood Advances (2021) Vol. 5, Iss. 20, pp. 3951-3959
Open Access | Times Cited: 58
Bleeding and thrombotic events in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study
Alexandre Mansour, Erwan Flécher, Matthieu Schmidt, et al.
Intensive Care Medicine (2022) Vol. 48, Iss. 8, pp. 1039-1052
Open Access | Times Cited: 56
Aging, inflammaging and immunosenescence as risk factors of severe COVID-19
Anteneh Mehari Tizazu, Hylemariam Mihiretie Mengist, Gebreselassie Demeke
Immunity & Ageing (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 56
The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications
Douglas B. Kell, Etheresia Pretorius
Biochemical Journal (2022) Vol. 479, Iss. 16, pp. 1653-1708
Open Access | Times Cited: 52
Pathophysiological mechanisms of thrombosis in acute and long COVID-19
Haijiao Jing, Xiaoming Wu, Mengqi Xiang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 49
Post-COVID Syndrome in Adults—An Overview
Rüdiger E. Scharf, Juan‐Manuel Anaya
Viruses (2023) Vol. 15, Iss. 3, pp. 675-675
Open Access | Times Cited: 33
NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis
Nicola Potere, Evan C. Garrad, Yogendra Kanthi, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 11, pp. 2046-2060
Open Access | Times Cited: 30
Status of major hemostatic components in the setting of COVID-19: the effect on endothelium, platelets, coagulation factors, fibrinolytic system, and complement
Mohammad Sayyadi, Saeed Hassani, Mahmood Shams, et al.
Annals of Hematology (2023) Vol. 102, Iss. 6, pp. 1307-1322
Open Access | Times Cited: 23
Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19
R. K. Subbarao Malireddi, Bhesh Raj Sharma, Thirumala‐Devi Kanneganti
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 615-645
Closed Access | Times Cited: 8


Revista de Hematología (2024) Vol. 24, Iss. 3
Open Access | Times Cited: 7
Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies
Satoshi Gando, Takeshi Wada
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 44
SARS‐CoV‐2 infection induces soluble platelet activation markers and PAI‐1 in the early moderate stage of COVID‐19
Abaher O. Al‐Tamimi, Ayesha M. Yusuf, Manju Nidagodu Jayakumar, et al.
International Journal of Laboratory Hematology (2022) Vol. 44, Iss. 4, pp. 712-721
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top